Topomer-CoMFA study of tricyclic azepine derivatives-EGFR inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Jae Yoon | - |
dc.contributor.author | Pasha, F. A. | - |
dc.contributor.author | Chung, Hwanwon | - |
dc.contributor.author | Yang, Beom-Seolk | - |
dc.contributor.author | Lee, Cheolju | - |
dc.contributor.author | Oh, Jung Soo | - |
dc.contributor.author | Moon, Myoung-Woon | - |
dc.contributor.author | Cho, Seung Joo | - |
dc.contributor.author | Cho, Art E. | - |
dc.date.accessioned | 2021-09-09T09:55:20Z | - |
dc.date.available | 2021-09-09T09:55:20Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2008-03-31 | - |
dc.identifier.issn | 1738-642X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/123868 | - |
dc.description.abstract | EGFR has been intensively investigated as a target to block the signal transduction pathway which stimulates cancer growth and metastasis. Studies about structure-activity relationship for tricyclic azepine derivatives were performed with topomer-CoMFA. The derived topomer-CoMFA model with steric and electrostatic field parameters based on fragment units gave reasonable statistics (q(2)=0.561, r(2)=0.679). The model explains why a halogen atom at the meta position of aniline is important to increases inhibitory activity. This comes from an electrostatically negative groups are favored near this region. The model also shows that there are sterically favored regions around methoxy group extended from oxazepine derivatives. The findings about steric and electrostatic effects can be utilized for designing new inhibitors. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC TOXICOGENOMICS & TOXICOPROTEOMICS | - |
dc.subject | GROWTH-FACTOR RECEPTOR | - |
dc.subject | TYROSINE KINASE INHIBITORS | - |
dc.subject | DESIGN | - |
dc.subject | THERAPY | - |
dc.title | Topomer-CoMFA study of tricyclic azepine derivatives-EGFR inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Art E. | - |
dc.identifier.wosid | 000254600500012 | - |
dc.identifier.bibliographicCitation | MOLECULAR & CELLULAR TOXICOLOGY, v.4, no.1, pp.78 - 84 | - |
dc.relation.isPartOf | MOLECULAR & CELLULAR TOXICOLOGY | - |
dc.citation.title | MOLECULAR & CELLULAR TOXICOLOGY | - |
dc.citation.volume | 4 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 78 | - |
dc.citation.endPage | 84 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001465498 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | TYROSINE KINASE INHIBITORS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | topomer-CoMFA | - |
dc.subject.keywordAuthor | EGFR | - |
dc.subject.keywordAuthor | QSAR | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.